{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:36:47Z","timestamp":1790753807860,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-F4-2011-18 280873"],"award-info":[{"award-number":["HEALTH-F4-2011-18 280873"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00162","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T03:18:40Z","timestamp":1461813520000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance"],"prefix":"10.3389","volume":"7","author":[{"given":"Alexander","family":"Badamchi-Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette T.","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Barinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Tregoning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"B1","volume-title":"Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases: Overview and Estimates","author":"WHO","year":"2001"},{"key":"B2","volume-title":"Sexually Transmitted Disease Surveillance 2010","author":"CDC","year":"2010"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1128\/IAI.00622-10","article-title":"CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection","volume":"78","author":"Farris","year":"2010","journal-title":"Infect Immun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Igietseme","year":"2000","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/IAI.57.4.1040-1049.1989","article-title":"Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars","volume":"57","author":"Yuan","year":"1989","journal-title":"Infect Immun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1743-422X-10-102","article-title":"Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge","volume":"10","author":"Eugene","year":"2013","journal-title":"Virol J"},{"key":"B13","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1128\/IAI.63.9.3302-3308.1995","article-title":"CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract","volume":"63","author":"Su","year":"1995","journal-title":"Infect Immun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.180.5.3375","article-title":"Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.0019-2805.2001.01354.x","article-title":"Fc receptor regulation of protective immunity against Chlamydia trachomatis","volume":"105","author":"Moore","year":"2002","journal-title":"Immunology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e84707","DOI":"10.1371\/journal.pone.0084707","article-title":"Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen","volume":"9","author":"McKay","year":"2014","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.PLAS-0028-2014","article-title":"Using plasmids as DNA vaccines for infectious diseases","volume":"2","author":"Tregoning","year":"2014","journal-title":"Microbiol Spectr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e101591","DOI":"10.1371\/journal.pone.0101591","article-title":"Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial","volume":"9","author":"Hayton","year":"2014","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0131748","DOI":"10.1371\/journal.pone.0131748","article-title":"HIV-DNA given with or without intradermal electroporation is safe and highly immunogenic in healthy swedish HIV-1 DNA\/MVA vaccinees: a phase I randomized trial","volume":"10","author":"Nilsson","year":"2015","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0264-410X(97)00226-0","article-title":"Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime\/MVA boost vaccination regime","volume":"16","author":"Hanke","year":"1998","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/S0264-410X(01)00086-X","article-title":"Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens","volume":"19","author":"Van Der Burg","year":"2001","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e13171","DOI":"10.1371\/journal.pone.0013171","article-title":"Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B- and T-cell epitopes: worldwide survey","volume":"5","author":"Nunes","year":"2010","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/molbev\/msp077","article-title":"FastTree: computing large minimum evolution trees with profiles instead of a distance matrix","volume":"26","author":"Price","year":"2009","journal-title":"Mol Biol Evol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"Unit 11A 11","DOI":"10.1002\/9780471729259.mc11a01s00","article-title":"Cultivation and laboratory maintenance of Chlamydia trachomatis","volume":"Chapter 11","author":"Scidmore","year":"2005","journal-title":"Curr Protoc Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1128\/IAI.01118-10","article-title":"Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum","volume":"79","author":"O\u2019Connell","year":"2011","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1016\/j.vaccine.2012.01.017","article-title":"High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge","volume":"30","author":"Picard","year":"2012","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0141209","DOI":"10.1371\/journal.pone.0141209","article-title":"Intramuscular immunisation with chlamydial proteins induces Chlamydia trachomatis specific ocular antibodies","volume":"10","author":"Badamchi-Zadeh","year":"2015","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1128\/JCM.33.12.3194-3197.1995","article-title":"Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR","volume":"33","author":"Lan","year":"1995","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/JCM.38.6.2292-2296.2000","article-title":"Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?","volume":"38","author":"Morre","year":"2000","journal-title":"J Clin Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00007435-200304000-00016","article-title":"Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996","volume":"30","author":"Suchland","year":"2003","journal-title":"Sex Transm Dis"},{"key":"B34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7883\/yoken.JJID.2005.211","article-title":"Distribution of Chlamydia trachomatis serovars among female prostitutes and non-prostitutes in Thailand, and non-prostitutes in Japan during the mid-90s","volume":"58","author":"Yamazaki","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/JCM.02076-06","article-title":"Distribution study of Chlamydia trachomatis serovars among high-risk women in China performed using PCR-restriction fragment length polymorphism genotyping","volume":"45","author":"Gao","year":"2007","journal-title":"J Clin Microbiol"},{"key":"B36","first-page":"134","article-title":"Chlamydia trachomatis infection and distribution of serovars in the Eastern Highlands Province, Papua New Guinea","volume":"50","author":"Suarkia","year":"2007","journal-title":"P N G Med J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1128\/JCM.01493-07","article-title":"Chlamydia trachomatis serovars among strains isolated from members of rural indigenous communities and urban populations in Australia","volume":"46","author":"Bandea","year":"2008","journal-title":"J Clin Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/mi.2007.19","article-title":"Chlamydia trachomatis infection: host immune responses and potential vaccines","volume":"1","author":"Hafner","year":"2008","journal-title":"Mucosal Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10096-008-0650-z","article-title":"Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy","volume":"28","author":"Donati","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1099\/jmm.0.008607-0","article-title":"Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary","volume":"58","author":"Petrovay","year":"2009","journal-title":"J Med Microbiol"},{"issue":"Suppl B","key":"B41","first-page":"33","article-title":"Chlamydia trachomatis serovar distributions in Russian men and women: a comparison with Dutch serovar distributions","volume":"45","author":"Smelov","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-0500-3-34","article-title":"Distribution study of Chlamydia trachomatis genotypes in symptomatic patients in Buenos Aires, Argentina: association between genotype E and neonatal conjunctivitis","volume":"3","author":"Gallo Vaulet","year":"2010","journal-title":"BMC Res Notes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/JCM.00586-10","article-title":"Chlamydia trachomatis serovar distribution and Neisseria gonorrhoeae coinfection in male patients with urethritis in Greece","volume":"48","author":"Papadogeorgakis","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1016\/j.vaccine.2010.08.068","article-title":"Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1","volume":"28","author":"Douglas","year":"2010","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vaccine.2011.10.086","article-title":"Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG\/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection","volume":"30","author":"Brown","year":"2012","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.vaccine.2010.12.042","article-title":"Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa","volume":"29","author":"Schautteet","year":"2011","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1016\/j.vaccine.2004.02.032","article-title":"DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model","volume":"22","author":"Penttila","year":"2004","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e10768","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2010","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/IAI.65.6.2145-2152.1997","article-title":"Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice","volume":"65","author":"Cotter","year":"1997","journal-title":"Infect Immun"},{"key":"B53","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/IAI.67.10.5518-5521.1999","article-title":"Role of gamma interferon in controlling murine chlamydial genital tract infection","volume":"67","author":"Ito","year":"1999","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/IAI.65.7.2693-2699.1997","article-title":"Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection","volume":"65","author":"Peterson","year":"1997","journal-title":"Infect Immun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/icb.2013.110","article-title":"Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens","volume":"92","author":"Armitage","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1172\/JCI0215640","article-title":"Immune complex-mediated antigen presentation induces tumor immunity","volume":"110","author":"Rafiq","year":"2002","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/jcp.2004.021543","article-title":"Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum","volume":"58","author":"Lyons","year":"2005","journal-title":"J Clin Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T01:30:52Z","timestamp":1718501452000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00162\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":57,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00162","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}